Lexitas Pharma Services, a Leading Ophthalmology CRO, Announces the Acquisition of Erie Retina Research, CASExERIE and Element Erie | National Business
DURHAM, N.C.–(BUSINESS WIRE)–May 19, 2026– Lexitas Pharma Services, a portfolio company of QHP Capital, is pleased to announce…